The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users
Open accessAbstract
The objective of this study was to compare sociodemographic, drug, and sexual risk characteristics between hepatitis C virus (HCV) baseline positive and negative young (13-24 years) injection drug users (IDUs) and to determine prospective risk factors for HCV seroconversion among the youth. Data were collected through the Vancouver Injection Drug Users Study (VIDUS). To date, more than 1,400 Vancouver-area IDUs have been enrolled and followed up; 234 were aged 24 years and younger. Semiannually, participants have completed an interviewer-administered questionnaire and have undergone serologic testing for human immunodeficiency virus (HIV) and HCV. Univariate and multivariate logistic regression analyses were undertaken to investigate predictors of baseline HCV positivity. In the multivariate analyses, Cox regression models with time-dependent covariates were used to identify predictors of HCV seroconversion. Of the 232 young injectors, 107 (46%) were HCV positive at baseline and a further 37 HCV seroconverted during the study period for an incidence rate of 37.3 per 100 person-years. Baseline positivity was associated with Aboriginal ancestry, older age, greater number of years injecting drugs, recent incarceration, sex trade work, more than 100 lifetime sexual partners, a previous sexually transmitted disease, living in the IDU epicenter, and injection more than once per day of heroin, cocaine, and speedball. Factors independently associated with HCV seroconversion were having a partner who uses injection drugs, requiring help to inject, and injection of cocaine more than once daily. In conclusion, unlike older IDUs, more than one half of young injectors were HCV negative at recruitment. Thus, there is a window of opportunity for prevention. However, the incidence rate of HCV among these young IDUs is alarming, suggesting that the opportunity to intervene is exceedingly small.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Prevalence of Hepatitis C Virus Infection in the United States, 1988 through 1994
Alter, M. J., Kruszon-Moran, D., Nainan, O. V., McQuillan, G. M., Gao, F., Moyer, L. A., Kaslow, R. A., & Margolis, H. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410802 · Cited by 2,992
[Gastric adenocarcinoma and kidney transplantation].
Barrio, J., García-Bengoechea, M., Emparanza, J. I., & Arenas, J. I. (1998) · PubMed · Cited by 1,132
Treatment of Acute Hepatitis C with Interferon Alfa-2b
Jaeckel, E., Cornberg, M., Wedemeyer, H., Santantonio, T., Mayer, J., Zankel, M., Pastore, G., Dietrich, M., Trautwein, C., & Manns, M. P. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011232 · Cited by 800
Garfein, R. S., Vlahov, D., Galai, N., Doherty, M. C., & Nelson, K. E. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.5.655 · Cited by 690
Needle exchange is not enough: lessons from the Vancouver injecting drug use study
Strathdee, S. A., Patrick, D. M., Currie, S. L., Cornelisse, P. G. A., Rekart, M. L., Montaner, J. S. G., Schechter, M. T., & OʼShaughnessy, M. V. (1997) · AIDS · doi:10.1097/00002030-199708000-00001 · Cited by 661
Self-citationConry-Cantilena, C., VanRaden, M., Gibble, J., Melpolder, J., Shakil, A. O., Viladomiu, L., Cheung, L., DiBisceglie, A., Hoofnagle, J., Shih, J. W., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342602 · Cited by 627
Sharing of drug preparation equipment as a risk factor for hepatitis C
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.1.42 · Cited by 500
Prevalence and Incidence of Hepatitis C Virus Infection Among Young Adult Injection Drug Users
Garfein, R. S., Doherty, M. C., Monterroso, E. R., Thomas, D. L., Nelson, K. E., & Vlahov, D. (1998) · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · doi:10.1097/00042560-199802001-00004 · Cited by 346
Hahn, J. A., Page-Shafer, K., Lum, P. J., Ochoa, K., & Moss, A. R. (2001) · Hepatology · doi:10.1053/jhep.2001.25759 · Cited by 204
Patrick, D. M., TYNDALL, M. W., Cornelisse, P., Li, K. K., Sherlock, C. H., Rekart, M. L., Strathdee, S. A., Currie, S. L., Schechter, M. T., & O’Shaughnessy, M. V. (2001) · Europe PMC (PubMed Central) · Cited by 203
Self-citationCorrelates of HIV infection among young adult short-term injection drug users
Doherty, M. C., Garfein, R. S., Monterroso, E., Brown, D., & Vlahov, D. (2000) · AIDS · doi:10.1097/00002030-200004140-00011 · Cited by 180
Schechter, M. T., Strathdee, S. A., Cornelisse, P. G. A., Currie, S., Patrick, D. M., Rekart, M. L., & O‚Shaughnessy, M. V. (1999) · AIDS · doi:10.1097/00002030-199904160-00002 · Cited by 172
Self-citationKral, A. H., Molnar, B. E., Booth, R. E., & Watters, J. K. (1997) · International Journal of STD & AIDS · doi:10.1258/0956462971919651 · Cited by 161
Thorpe, L. E., Ouellet, L. J., Levy, J. R., Williams, I. T., & Monterroso, E. R. (2000) · The Journal of Infectious Diseases · doi:10.1086/317607 · Cited by 160
Commercial Tattooing as a Potentially Important Source of Hepatitis C Infection
Haley, R. W., & FISCHER, R. P. (2001) · Medicine · doi:10.1097/00005792-200103000-00006 · Cited by 150
Broers, B., Junet, C., Bourquin, M., Déglon, J., Perrin, L. H., & Hirschel, B. J. (1998) · AIDS · doi:10.1097/00002030-199815000-00018 · Cited by 121
Clements, K., Gleghorn, A. A., Garcia, D., Katz, M. H., & Marx, R. (1997) · Journal of Adolescent Health · doi:10.1016/s1054-139x(97)00033-5 · Cited by 112
Latkin, C. A., & Vlahov, D. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.93811917.x · Cited by 111
Public Health and Changes in Illicit Drug Prices
Hagan, H. (2001) · American Journal of Public Health · doi:10.2105/ajph.91.9.1350 · Cited by 106
Seal, K. H. (2000) · Western Journal of Medicine · doi:10.1136/ewjm.172.1.16 · Cited by 66
Parker, M. (2000) · Journal of Biosocial Science · doi:10.1017/s0021932000222839 · Cited by 63
HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary
Ford, P. M. (2000) · QJM · doi:10.1093/qjmed/93.2.113 · Cited by 60
Hepatitis C virus infection in Italian intravenous drug users: epidemiological and clinical aspects
Galeazzi, B., Tufano, A., Barbierato, E., & Bortolotti, F. (1995) · Liver International · doi:10.1111/j.1600-0676.1995.tb00672.x · Cited by 57
Martinez, T., Gleghorn, A. A., Marx, R., Clements, K., Boman, M., & Katz, M. H. (1998) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1998.10399665 · Cited by 56
Evaluation der Gassenzimmer I, II und III in Basel
Ronco, C., Spuhler, G., Coda, P., & Sch�pfer, R. (1996) · Sozial- und Präventivmedizin · doi:10.1007/bf01318589 · Cited by 35
HIV incidence and associated risk factors among young injection drug users
Miller, C. L., TYNDALL, M. W., Spittal, P. M., Li, K. K., Laliberté, N., & Schechter, M. T. (2002) · AIDS · doi:10.1097/00002030-200202150-00025 · Cited by 20
Self-citation
Cited by
Global epidemiology of hepatitis C virus infection
Shepard, C. W., Finelli, L., & Alter, M. J. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70216-4 · Cited by 2,758
McNeil, R., Small, W., Wood, E., & Kerr, T. (2014) · Social Science & Medicine · doi:10.1016/j.socscimed.2014.01.010 · Cited by 284
Goodman, A., Fleming, K., Markwick, N., Morrison, T., Lagimodiere, L., & Kerr, T. (2017) · Social Science & Medicine · doi:10.1016/j.socscimed.2017.01.053 · Cited by 253
Rhodes, T., Wagner, K., Strathdee, S. A., Shannon, K., Davidson, P., & Bourgois, P. (2012) · Rethinking Social Epidemiology · doi:10.1007/978-94-007-2138-8_10 · Cited by 220
Des Jarlais, D. C., Perlis, T., Arasteh, K., Torian, L. V., Hagan, H., Beatrice, S., Smith, L., Wethers, J., Milliken, J., Mildvan, D., et al. (2005) · AIDS · doi:10.1097/01.aids.0000192066.86410.8c · Cited by 163
Metadata
- Authors
- Miller, C. L., Johnston, C., Spittal, P. M., Li, K., LaLiberté, N., Montaner, J. S. G., & Schechter, M. T.
- Venue
- Hepatology
- Published
- 2002-09
- Volume
- 36
- Issue
- 3
- Pages
- 737-742
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2087557729
- Cited by
- 259
- References
- 26
- FWCI
- 11.17
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.